Form EFFECT Lyra Therapeutics, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 26, 2026 |
| Accession Number: | 0001193125-26-124474 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Skanska builds industrial facility in Karmøy, Norway, for NOK 1.1 billion, about SEK 1.0 billion
- HEALBE's Technology Powers SHARP's First Health-Focused Smartwatch
- U.S. Gambling Industry Spent 8.7x More on Celebrity Endorsements Than on Responsible Gambling Communications in 2025, 5W Research Division Finds.
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
